InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Viking Therapeutics, Inc.

VKTX Clue Score29
United States Fiscal year ends December CIK 0001607678
$28.51 +2.81% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $28.51 +375.96% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 11 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.0Operating income−13.8Net income−14.7Fiscal year 2017Revenue0.0Operating income−19.1Net income−20.6Fiscal year 2018Revenue0.0Operating income−26.2Net income−22.1Fiscal year 2019Revenue0.0Operating income−32.7Net income−25.8Fiscal year 2020Revenue0.0Operating income−42.7Net income−39.5Fiscal year 2021Revenue0.0Operating income−55.7Net income−55.0EPS, diluted−0.71Fiscal year 2022Revenue0.0Operating income−70.4Net income−68.9EPS, diluted−0.90Fiscal year 2023Revenue0.0Operating income−100.8Net income−85.9EPS, diluted−0.91Fiscal year 2024Revenue0.0Operating income−150.9Net income−110.0EPS, diluted−1.01Fiscal year 2025Revenue0.0Operating income−393.3Net income−359.6EPS, diluted−3.19
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Growth
Operating income −13.8 −19.1 −26.2 −32.7 −42.7 −55.7 −70.4 −100.8 −150.9 −393.3
Net income −14.7 −20.6 −22.1 −25.8 −39.5 −55.0 −68.9 −85.9 −110.0 −359.6
Growth
EPS, diluted n/a n/a n/a n/a n/a −0.71 −0.90 −0.91 −1.01 −3.19
Growth

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2016Operating cash flow−11.1Buybacks−0.0Fiscal year 2017Operating cash flow−14.8Fiscal year 2018Operating cash flow−18.8Fiscal year 2019Operating cash flow−24.8Fiscal year 2020Operating cash flow−21.8Fiscal year 2021Operating cash flow−47.6Fiscal year 2022Operating cash flow−48.4Buybacks−6.8Fiscal year 2023Operating cash flow−73.4Fiscal year 2024Operating cash flow−87.8Fiscal year 2025Operating cash flow−278.7
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −11.1 −14.8 −18.8 −24.8 −21.8 −47.6 −48.4 −73.4 −87.8 −278.7
Buybacks −0.0 n/a n/a n/a n/a n/a −6.8 n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash3.1Shareholders’ equity8.0Fiscal year 2017Cash9.0Shareholders’ equity13.5Fiscal year 2018Cash24.8Shareholders’ equity297.8Fiscal year 2019Cash8.4Shareholders’ equity277.1Fiscal year 2020Cash29.1Shareholders’ equity244.3Fiscal year 2021Cash26.4Shareholders’ equity201.9Fiscal year 2022Cash36.6Shareholders’ equity145.3Fiscal year 2023Cash55.5Shareholders’ equity348.4Fiscal year 2024Cash26.7Shareholders’ equity880.3Fiscal year 2025Cash165.8Shareholders’ equity639.1
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 3.1 9.0 24.8 8.4 29.1 26.4 36.6 55.5 26.7 165.8
Shareholders’ equity 8.0 13.5 297.8 277.1 244.3 201.9 145.3 348.4 880.3 639.1

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Growth
9.0 13.7 19.0 23.6 31.9 45.0 54.2 63.8 101.6 345.0
4.8 5.3 7.1 9.1 10.7 10.7 16.1 37.0 49.3 48.4
−13.8 −19.1 −26.2 −32.7 −42.7 −55.7 −70.4 −100.8 −150.9 −393.3
Growth
n/a n/a n/a n/a n/a n/a n/a −85.9 −110.0 −359.6
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
−14.7 −20.6 −22.1 −25.8 −39.5 −55.0 −68.9 −85.9 −110.0 −359.6
Growth
Per share
n/a n/a n/a n/a n/a −0.71 −0.90 −0.91 −1.01 −3.19
n/a n/a n/a n/a n/a −0.71 −0.90 −0.91 −1.01 −3.19
Growth
n/a n/a n/a n/a n/a 77.2 76.8 94.3 109.0 112.7
n/a n/a n/a n/a n/a 77.2 76.8 94.3 109.0 112.7
Growth −0.5% +22.8% +15.6% +3.3%

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 10 of 10 years on file.